Since SFN modulated AKT/mTOR signaling and acted on CDKs and cyclins, suppression of the AKT/mTOR pathway and alterations of the CDK–cyclin axis may contribute to SFN’s effects on tumor growth and proliferation. The gene discussed is MTOR; the disease is neoplasm.